NM_000059.4(BRCA2):c.2484T>C (p.Tyr828=) AND not specified

Germline classification:: Benign/Likely benign (2 submissions)
Last evaluated:: Nov 8, 2020
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000123953.7

Allele description [Variation Report for NM_000059.4(BRCA2):c.2484T>C (p.Tyr828=)]

NM_000059.4(BRCA2):c.2484T>C (p.Tyr828=)

Gene:

BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

13q13.1

Genomic location:

Preferred name:

NM_000059.4(BRCA2):c.2484T>C (p.Tyr828=)

Other names:

p.Y828Y:TAT>TAC

HGVS:

NC_000013.11:g.32336839T>C
NG_012772.3:g.26360T>C
NM_000059.4:c.2484T>CMANE SELECT
NP_000050.2:p.Tyr828=
NP_000050.3:p.Tyr828=
LRG_293t1:c.2484T>C
LRG_293:g.26360T>C
LRG_293p1:p.Tyr828=
NC_000013.10:g.32910976T>C
NM_000059.3:c.2484T>C
p.Tyr828Tyr
p.Y828Y

Links:

dbSNP: rs45619134

NCBI 1000 Genomes Browser:

rs45619134

Molecular consequence:

NM_000059.4:c.2484T>C - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000167344	GeneDx	criteria provided, single submitter (GeneDx Variant Classification (06012015))	Benign (Oct 18, 2013)	germline	clinical testing	Citation Link,
SCV000919014	Women's Health and Genetics/Laboratory Corporation of America, LabCorp	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015)	Likely benign (Nov 8, 2020)	germline	clinical testing	PubMed (2) [See all records that cite these PMIDs] 18060494, 15944772 Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000167344

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification (06012015))

Benign
(Oct 18, 2013)

germline

clinical testing

Citation Link,

SCV000919014

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)

Likely benign
(Nov 8, 2020)

germline

clinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain.

Esteban Cardeñosa E, Bolufer Gilabert P, Palanca Suela S, Oltra Soler S, Barragán González E, Velasco Sampedro E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E; Group for Assessment of Hereditary Cancer of Valencia Community..

Breast Cancer Res Treat. 2008 Nov;112(1):69-73. Epub 2007 Dec 1.

PubMed [citation]

PMID:: 18060494

Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population.

Salgado J, Zabalegui N, García-Amigot F, Gil MC, González MS, García-Foncillas J.

Oncol Rep. 2005 Jul;14(1):85-8.

PubMed [citation]

PMID:: 15944772

Details of each submission

From GeneDx, SCV000167344.11

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000919014.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (2)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 10, 2024

ClinVar

Relating variation to medicine